Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy

被引:0
|
作者
Laura Obici
Senda Ajroud-Driss
Kon-Ping Lin
John L. Berk
Julian D. Gillmore
Parag Kale
Haruki Koike
David Danese
Emre Aldinc
Chongshu Chen
John Vest
David Adams
机构
[1] IRCCS Fondazione Policlinico San Matteo,Amyloidosis Research and Treatment Centre
[2] Northwestern University Feinberg School of Medicine,Department of Neurology
[3] Taipei Veterans General Hospital,Department of Neurology
[4] Boston Medical Center,National Amyloidosis Centre, Royal Free Hospital
[5] University College London,Department of Neurology
[6] Baylor University Medical Center,Neurology Department
[7] Nagoya University Graduate School of Medicine,undefined
[8] Alnylam Pharmaceuticals,undefined
[9] Université Paris-Saclay,undefined
[10] U1195,undefined
[11] INSERM,undefined
[12] AP-HP,undefined
[13] CHU Bicêtre,undefined
关键词
ATTRv amyloidosis; hATTR amyloidosis; Nutritional status; Physical function; Polyneuropathy; Quality of life; RNA interference; Vutrisiran;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1759 / 1775
页数:16
相关论文
共 50 条
  • [21] Patisiran in hereditary transthyretin-mediated amyloidosis
    Luigetti, Marco
    Servidei, Serenella
    LANCET NEUROLOGY, 2021, 20 (01): : 21 - 23
  • [22] Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation
    Schmidt, Hartmut H.
    Wixner, Jonas
    Plante-Bordeneuve, Violaine
    Munoz-Beamud, Francisco
    Llado, Laura
    Gillmore, Julian D.
    Mazzeo, Anna
    Li, Xingyu
    Arum, Seth
    Jay, Patrick Y.
    Adams, David
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (06) : 1646 - 1657
  • [23] HELIOS-A: 9-MONTH RESULTS FROM THE RANDOMIZED TREATMENT EXTENSION PERIOD OF VUTRISIRAN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY
    Obici, Laura
    Polydefkis, Michael
    Gonzalez-Duarte, Alejandra
    Waddington-Cruz, Marcia
    Sekijima, Yoshiki
    Gillmore, Julian D.
    Yureneva, Elena
    Badri, Prajakta
    Chen, Chongshu
    Sweetser, Marianne
    Vest, John
    Adams, David
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2023, 28 : S40 - S40
  • [24] Identifying Mixed Phenotype: Evaluating the Presence of Polyneuropathy in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Cardiomyopathy
    Grogan, Martha
    Hawkins, Philip N.
    Kristen, Arnt V.
    Berk, John L.
    Suhr, Ole B.
    Lin, Hollis
    Merkel, Madeline
    McManus, Anastasia
    Powell, Christine
    Vest, John
    Karsten, Verena
    Judge, Daniel P.
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S9 - S10
  • [25] Practical Guidance for the Use of Patisiran in the Management of Polyneuropathy in Hereditary Transthyretin-Mediated Amyloidosis
    Dixon, Stacy
    Kang, Xuan
    Quan, Dianna
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2023, 19 : 973 - 981
  • [26] Treatment with patisiran of a patient with hereditary transthyretin-mediated amyloidosis with stage 3 polyneuropathy
    Mueschen, Lars H.
    Koerner, Gudrun
    Gingele, Stefan
    Haenselmann, Anja
    Bavendiek, Udo
    Skripuletz, Thomas
    MUSCLE & NERVE, 2021, 64 (03) : E11 - E13
  • [27] Long-term Integrated Safety of Patisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
    Gillmore, Julian
    Berk, John
    Dispenzieri, Angela
    Polydefkis, Michael
    Gonzalez-Duarte, Alejandra
    Sekijima, Yoshiki
    Sweetser, Marianne T.
    Arum, Seth
    Wang, Jing Jing
    White, Matthew T.
    Maurer, Mathew
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S67 - S68
  • [28] IDENTIFYING MIXED PHENOTYPE: EVALUATING THE PRESENCE OF POLYNEUROPATHY IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH CARDIOMYOPATHY
    Grogan, Martha
    Hawkins, Philip
    Kristen, Arnt
    Berk, John
    Suhr, Ole B.
    Lin, Hollis
    Merkel, Madeline
    McManus, Anastasia
    Powell, Christine
    Vest, John
    Karsten, Verena
    Judge, Daniel
    MUSCLE & NERVE, 2020, 62 : S107 - S107
  • [29] Identifying Mixed Phenotype: Evaluating the Presence of Polyneuropathy in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Cardiomyopathy
    Merkel, Madeline
    Grogan, Martha
    Hawkins, Philip N.
    Kristen, Arnt V.
    Berk, John L.
    Suhr, Ole B.
    Lin, Hollis
    McManus, Anastasia
    Powell, Christine
    Vest, John
    Karsten, Verena
    Judge, Daniel P.
    NEUROLOGY, 2020, 94 (15)
  • [30] Long-term integrated safety of patisiran in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Gillmore, J.
    Berk, J.
    Dispenzieri, A.
    Polydefkis, M.
    Gonzalez-Duarte, A.
    Sekijima, Y.
    Sweetser, M. T.
    Arum, S.
    Wang, J. J.
    White, M. T.
    Maurer, M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2129 - 2129